JP Morgan Reinstates Underweight on Amarin Corp, Announces $13 Price Target
JP Morgan analyst Jessica Fye reinstates Amarin Corp (NASDAQ:AMRN) with a Underweight and announces $13 price target.
Read original at benzingaStocks · News reference
Amarin Says REDUCE-IT Post Hoc Analysis Showed About 30% Relative Risk Reduction In Major Adverse Cardiovascular Events Among Patients On Icosapent Ethyl At Least 1.5 Years; Hazard Ratio Of 0.73 Persisted After Discontinuation
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Aug 28, 2026, 12:16 PM
- Checked
- Aug 28, 2026, 12:16 PM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
8-K filing — AMARIN CORP PLC\UK (AMRN)
Filed: 2026-07-29 AccNo: 0001193125-26-323841 Size: 777 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits
Read original at edgarAmarin Corp Q2 Sales $42.211M Miss $44.550M Estimate
Read original at benzinga